Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

Abstract Background Multiple myeloma (MM) constitutes approximately 10% of hematological malignancies. Bisphosphonates have established themselves in solid organ metastasis and multiple myeloma lytic bone lesions by inhibiting osteoclast activation. Medication-related osteonecrosis of the jaw (MRONJ...

Full description

Bibliographic Details
Main Authors: Betul Taş Ozyurtseven, Istemi Serin, Ayse Feyda Nursal, Sacide Pehlivan, Mustafa Pehlivan
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Oral Health
Subjects:
Medication-related osteonecrosis of the jaws (MRONJ)
Bisphosphonate
Multiple myeloma
Endothelial nitric oxide synthase
Online Access:https://doi.org/10.1186/s12903-021-01634-9

Internet

https://doi.org/10.1186/s12903-021-01634-9

Similar Items